Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of ConcernArticle Published on 2022-10-142022-11-15 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Ability ACE2 binding antibody Antibody titer Antigen binding domain binding epitope characterized concern coronavirus 2 coronavirus disease COVID-19 COVID-19 neutralizing antibody Delta domains effective high affinity high stability highlight Infection introduced lung cell Neutralizing neutralizing antibody New omicron pathogen plasma Protein RBD respiratory SARS-CoV-2 SARS-CoV-2 receptor SARS-CoV-2 variant SARS-CoV-2 variants single-domain antibody Spike protein spike protein. suggested therapeutic option unique variable variant VNAR therapy was tested was used [DOI] 10.3390/ijms232012267 PMC 바로가기
Quantifying Mutational Response to Track the Evolution of SARS-CoV-2 Spike Variants: Introducing a Statistical-Mechanics-Guided Machine Learning MethodArticle Published on 2022-10-132022-11-16 Journal: The journal of physical chemistry. B [Category] COVID19(2023년), SARS, 변종, [키워드] accompanied Affect analysis approach average binary classification model characteristic concern Critical database defined Evolution function global public health help identify implication information interest machine learning Mutation mutations pathogenicity predict residue response SARS-CoV-2 sequence spike spike glycoprotein Stage statistical track variant virus VoC VOCs VOIs [DOI] 10.1021/acs.jpcb.2c04574 PMC 바로가기
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE networkArticle Published on 2022-10-082022-11-15 Journal: Trials [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] ≥75 years. adaptive addition advanced age age Analysis Antibody titre benefit BNT162b2 BNT162b2 (Comirnaty®) booster booster dose changes in Clinical course collected concern conducted COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine dose Endpoint enzyme-linked immunosorbent evaluate exploratory fourth dose humoral immune response immunosenescence include individual initial Intervention mRNA-1273 mRNA-1273 (Spikevax®) multicentre neutralising neutralising antibody titre Older Part Patient performed phase phase II primary endpoint protocol qPCR Quantitative randomisation randomised randomised controlled reactogenicity Research risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine secondary subgroup T cell response the primary endpoint Trial triggered vaccination Vaccine vaccine-induced immune response variants variants of concern VoC wild-type wild-type virus [DOI] 10.1186/s13063-022-06791-y PMC 바로가기
Systematic Down-Selection of Repurposed Drug Candidates for COVID-19Article Published on 2022-10-062022-11-15 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 변종, 신약개발, 치료제, [키워드] applied approved drug average candidate claimed Compound compounds concern COVID COVID-19 COVID-19 pandemic CoviRx.org Critical curated database disease Diseases drug drug candidate drugs effective Efficacy and safety effort eight evaluate Healthcare system healthcare worker infections mechanism methodology pandemic Prevent provide repurposing Safe safety profile SARS-CoV-2 Scientific community Therapies treating COVID-19 Treatment treatments. Vaccine variants of concern variants of concern (VOC) [DOI] 10.3390/ijms231911851 PMC 바로가기
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic reviewReview article Published on 2022-10-012022-10-05 Journal: Journal of clinical neuroscience : official journa [Category] 진단, [키워드] Abstract benefit booster dose Case report case sery concern COVID-19 COVID-19 vaccination COVID-19 vaccine disease dosage Efficacy eligible Exacerbation FIVE include Infection Multiple multiple sclerosis Patient patients Relapse reported Result risk searched second dose Side effects stimulate Symptom systematic review vaccination vaccination against COVID-19 Vaccine weakness Web of Science [DOI] 10.1016/j.jocn.2022.08.012 [Article Type] Review article
COVID-19 booster uptake among US adults: Assessing the impact of vaccine attributes, incentives, and context in a choice-based experimentResearch article Published on 2022-10-012022-10-05 Journal: Social science & medicine (1982) [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Administered Affect Assessing attribute attributes booster concern Conjoint experiment contagious COVID-19 COVID-19 vaccine Efficacy experiment Factor Guidance IMPROVE individual information initial less likelihood objective offer omicron predisposition protection provide Public acceptance public health public health messaging rationale receive reported Research Result significantly increased traits trials vaccinate vaccination vaccination against COVID-19 Vaccine variant [DOI] 10.1016/j.socscimed.2022.115277 [Article Type] Research article
Shedding of infectious SARS-CoV-2 despite vaccinationArticle Published on 2022-09-302022-11-15 Journal: PLoS Pathogens [Category] SARS, 변종, 치료기술, [키워드] caused concern COVID-19 COVID-19 case cycle threshold Delta delta variant determine Immune escape individual individuals Infectious virus Laboratory Mutation nasal swab no significant effect North America predominant RT-PCR SARS-CoV-2 SARS-CoV-2 vaccine Sex shedding specimen subset tested Testing vaccinated individual vaccination Vaccine [DOI] 10.1371/journal.ppat.1010876 PMC 바로가기
Dynamics of SARS-CoV-2 Variants of Concern in Vaccination Model City in the State of Sao Paulo, BrazilArticle Published on 2022-09-292022-11-16 Journal: Viruses [Category] SARS, 변종, [키워드] B.1.1.28 B.1.1.33 Brazil city Clinical outcome clinical outcomes Complete concern CoronaVac country COVID-19 COVID-19 vaccines death Delta Delta VOC Dynamics epidemic wave evaluate event Gamma Genome highest immunization infecting initial Lineage Mild Model molecular Molecular epidemiology morbidity morbidity and mortality Mortality MOST occurred omicron performed Phylogenetic analysis Prevent reduced reducing responsible SARS-CoV-2 SARS-CoV-2 variants significantly Sinovac state Surveillance the SARS-CoV-2 vaccination Vaccine variants of concern variants of concern (VOC). VoC was performed [DOI] 10.3390/v14102148 PMC 바로가기
Intrahost SARS-CoV-2 k-mer Identification Method (iSKIM) for Rapid Detection of Mutations of Concern Reveals Emergence of Global Mutation PatternsArticle Published on 2022-09-272022-11-15 Journal: Viruses [Category] SARS, 변종, 치료기술, [키워드] bioinformatics can be used computational genomics concern COVID-19 dataset detect detection emergence Frequency genome assembly Genome sequencing genomic genomic sequencing identification identify increases in Intrahost variation L452R Lineage lineages Mutation N501Y pattern Rapid raw data SARS-CoV-2 Sequencing spike Spread Surveillance the timing variant variants variants of concern variants of concern. Variation [DOI] 10.3390/v14102128 PMC 바로가기
Molecular Docking and In-Silico Analysis of Natural Biomolecules against Dengue, Ebola, Zika, SARS-CoV-2 Variants of Concern and Monkeypox VirusArticle Published on 2022-09-222022-11-15 Journal: International Journal of Molecular Sciences [Category] SARS, 변종, 진단, 치료제, [키워드] Amino acid AMP AMPs antimicrobial peptide Antiviral antiviral drug Antiviral treatment AutoDock vina B.1.617.2 Bacterial bacterial AMPs binding energy Biomolecule biomolecules Cell cell receptor cell surface receptors concern Control Dengue dengue virus determine develop docking docking score Ebola Ebola virus Effective vaccines envelope protein Evolution in silico increase in indicated Modification molecular molecular docking Monkeypox monkeypox. mutant natural Occurrence P.1 pathogenic viruses positive proline Protein receptors SARS-CoV-2 Secondary Metabolite specific neutralizing antibody tested the SARS-CoV-2 the spike protein therapeutic agents variant variants of SARS-CoV-2 viral cell viral surface virus virus was performed Zika Zika virus [DOI] 10.3390/ijms231911131 PMC 바로가기